These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Magnetic resonance tomography and localized proton spectroscopy in 2 siblings with Canavan's disease]. Engelbrecht V; Rassek M; Gärtner J; Kahn T; Mödder U Rofo; 1995 Sep; 163(3):238-44. PubMed ID: 7548871 [TBL] [Abstract][Full Text] [Related]
3. A case of Canavan disease: the first biochemically proven case in a Japanese girl. Hamaguchi H; Nihei K; Nakamoto N; Ezoe T; Naito H; Hara M; Yokota K; Inoue Y; Matsumoto I Brain Dev; 1993; 15(5):367-71. PubMed ID: 8279652 [TBL] [Abstract][Full Text] [Related]
4. Atypical clinical and radiological course of a patient with Canavan disease. Sarret C; Boespflug-Tanguy O; Rodriguez D Metab Brain Dis; 2016 Apr; 31(2):475-9. PubMed ID: 26586007 [TBL] [Abstract][Full Text] [Related]
5. Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRI. Janson CG; McPhee SW; Francis J; Shera D; Assadi M; Freese A; Hurh P; Haselgrove J; Wang DJ; Bilaniuk L; Leone P Neuropediatrics; 2006 Aug; 37(4):209-21. PubMed ID: 17177147 [TBL] [Abstract][Full Text] [Related]
6. Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by (13)C MRS and [1-(13)C]glucose infusion. Moreno A; Ross BD; Blüml S J Neurochem; 2001 Apr; 77(1):347-50. PubMed ID: 11279290 [TBL] [Abstract][Full Text] [Related]
8. Quantitative measurements with localized 1H MR spectroscopy in children with Canavan's disease. Wittsack HJ; Kugel H; Roth B; Heindel W J Magn Reson Imaging; 1996; 6(6):889-93. PubMed ID: 8956134 [TBL] [Abstract][Full Text] [Related]
9. Use of localized proton nuclear magnetic resonance spectroscopy in Canavan's disease. Aydinli N; Calişkan M; Calay M; Ozmen M Turk J Pediatr; 1998; 40(4):549-57. PubMed ID: 10028864 [TBL] [Abstract][Full Text] [Related]
10. [A case of Canavan-Van Bogaert-Bertrand leukodystrophy]. Mikhaĭlova SV; Zakharova EIu; Bukina AM; Il'ina ES; Pokrovskaia AIa; Fedoniuk ID; Bembeeva RTs; Petrukhin AS Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(4):50-4. PubMed ID: 15270300 [No Abstract] [Full Text] [Related]
11. Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease. Assadi M; Janson C; Wang DJ; Goldfarb O; Suri N; Bilaniuk L; Leone P Eur J Paediatr Neurol; 2010 Jul; 14(4):354-9. PubMed ID: 20034825 [TBL] [Abstract][Full Text] [Related]
12. Atypical MRI findings in Canavan disease: a patient with a mild course. Yalcinkaya C; Benbir G; Salomons GS; Karaarslan E; Rolland MO; Jakobs C; van der Knaap MS Neuropediatrics; 2005 Oct; 36(5):336-9. PubMed ID: 16217711 [TBL] [Abstract][Full Text] [Related]
13. [Canavan disease or N-acetyl aspartic aciduria: a case report]. Boughamoura L; Chaabane F; Tilouche S; Chabchoub I; Kabachi N; Tlili K; Yacoub M; Essoussi AS Arch Pediatr; 2007 Feb; 14(2):173-6. PubMed ID: 17196380 [TBL] [Abstract][Full Text] [Related]
14. New T530C mutation in the aspartoacylase gene caused Canavan disease with no correlation between severity and N-acetylaspartate excretion. Di Pietro V; Cavallari U; Amorini AM; Lazzarino G; Longo S; Poggiani C; Cavalli P; Tavazzi B Clin Biochem; 2013 Dec; 46(18):1902-4. PubMed ID: 24036223 [TBL] [Abstract][Full Text] [Related]
15. N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase. Francis JS; Wojtas I; Markov V; Gray SJ; McCown TJ; Samulski RJ; Bilaniuk LT; Wang DJ; De Vivo DC; Janson CG; Leone P Neurobiol Dis; 2016 Dec; 96():323-334. PubMed ID: 27717881 [TBL] [Abstract][Full Text] [Related]
16. Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy. von Jonquieres G; Spencer ZHT; Rowlands BD; Klugmann CB; Bongers A; Harasta AE; Parley KE; Cederholm J; Teahan O; Pickford R; Delerue F; Ittner LM; Fröhlich D; McLean CA; Don AS; Schneider M; Housley GD; Rae CD; Klugmann M Acta Neuropathol; 2018 Jan; 135(1):95-113. PubMed ID: 29116375 [TBL] [Abstract][Full Text] [Related]
17. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study. Braun KP; van Eijsden P; Vandertop WP; de Graaf RA; Gooskens RH; Tulleken KA; Nicolay K J Neurosurg; 1999 Oct; 91(4):660-8. PubMed ID: 10507389 [TBL] [Abstract][Full Text] [Related]
18. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study. Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520 [TBL] [Abstract][Full Text] [Related]
19. Canavan's spongiform leukodystrophy: a clinical anatomy of a genetic metabolic CNS disease. Baslow MH J Mol Neurosci; 2000 Oct; 15(2):61-9. PubMed ID: 11220786 [TBL] [Abstract][Full Text] [Related]
20. Canavan disease. Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms. Baslow MH; Resnik TR J Mol Neurosci; 1997 Oct; 9(2):109-25. PubMed ID: 9407392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]